Medplus Health Services Achieves 52-Week High Amid Strong Financial Performance

Medplus Health Services has made headlines today as its stock price reached a new 52-week high of Rs. 890, marking a significant milestone for the midcap retailing company. The stock has shown impressive performance, outperforming its sector by 5.31% and achieving a consecutive gain of 7.27% over the last two days. Opening with a gain of 4.14%, Medplus Health's intraday high reflects a robust market position.
In terms of financial metrics, Medplus Health Services has demonstrated strong growth, with a net profit increase of 18.53% reported in December 2024. The company has consistently delivered positive results over the last two quarters, showcasing a return on capital employed (ROCE) of 8.14%, the highest in its history. Additionally, the inventory turnover ratio stands at an impressive 4.47 times, indicating efficient management of stock.

Over the past year, Medplus has generated a return of 24.14%, significantly outpacing the BSE 500's return of 8.77%. With its stock trading above all key moving averages, Medplus Health Services is positioned strongly in the current market landscape.